Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Eikon Therapeutics, Inc. | 268,176 | reported | 02 Mar 2026 | tx 4+553,033−2,124,403 |
| Merck & Co., Inc. | 151,029 | reported | 01 May 2020 | tx 20+2,022,255−522,296 |
| Microbot Medical Inc. | 13,000 | reported | 14 Dec 2012 | tx 7+61,000 |
| NGM BIOPHARMACEUTICALS INC | 0 | reported | 05 Apr 2024 | tx 6+148,867−148,867 |
| AMGEN INC | 0 | reported | 02 Feb 2012 | tx 39+766,332−544,947 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 02 Mar 2026 | GRANT_AWARD | Eikon Therapeutics, Inc. | 268,176 | 0.00 USD | deriv |
| 06 Feb 2026 | CONVERSION | Eikon Therapeutics, Inc. | 284,857 | — | |
| 06 Feb 2026 | CONVERSION | Eikon Therapeutics, Inc. | 855,512 | — | deriv |
| 06 Feb 2026 | CONVERSION | Eikon Therapeutics, Inc. | 1,268,891 | — | deriv |
| 05 Apr 2024 | OTHER | NGM BIOPHARMACEUTICALS INC | 78,407 | — | deriv |
| 05 Apr 2024 | OTHER | NGM BIOPHARMACEUTICALS INC | 46,238 | — | deriv |
| 05 Apr 2024 | OTHER | NGM BIOPHARMACEUTICALS INC | 24,222 | — | deriv |
| 10 May 2023 | GRANT_AWARD | NGM BIOPHARMACEUTICALS INC | 78,407 | 0.00 USD | deriv |
| 18 May 2022 | GRANT_AWARD | NGM BIOPHARMACEUTICALS INC | 24,222 | 0.00 USD | deriv |
| 08 Jun 2021 | GRANT_AWARD | NGM BIOPHARMACEUTICALS INC | 46,238 | 0.00 USD | deriv |
| 01 May 2020 | GRANT_AWARD | Merck & Co., Inc. | 151,029 | 0.00 USD | deriv |
| 28 Feb 2020 | GRANT_AWARD | Merck & Co., Inc. | 35,049 | 76.56 USD | |
| 03 May 2019 | GRANT_AWARD | Merck & Co., Inc. | 141,134 | 0.00 USD | deriv |
| 25 Feb 2019 | GRANT_AWARD | Merck & Co., Inc. | 32,937 | 80.38 USD | |
| 08 Nov 2018 | SALE | Merck & Co., Inc. | 225,443 | 75.27 USD | |
| 08 Nov 2018 | EXERCISE | Merck & Co., Inc. | 225,443 | 44.98 USD | |
| 08 Nov 2018 | EXERCISE | Merck & Co., Inc. | 225,443 | 0.00 USD | deriv |
| 04 May 2018 | GRANT_AWARD | Merck & Co., Inc. | 146,383 | 0.00 USD | deriv |
| 27 Feb 2018 | GRANT_AWARD | Merck & Co., Inc. | 34,931 | 54.72 USD | |
| 05 May 2017 | GRANT_AWARD | Merck & Co., Inc. | 171,184 | 0.00 USD | deriv |
| 27 Feb 2017 | GRANT_AWARD | Merck & Co., Inc. | 32,670 | 65.85 USD | |
| 10 May 2016 | GRANT_AWARD | Merck & Co., Inc. | 271,647 | 0.00 USD | deriv |
| 06 May 2016 | TAX_WITHHOLDING | Merck & Co., Inc. | 26,946 | 54.09 USD | |
| 06 May 2016 | EXERCISE | Merck & Co., Inc. | 44,464 | 0.00 USD | |
| 06 May 2016 | EXERCISE | Merck & Co., Inc. | 44,464 | 54.09 USD | deriv |